Article info

Original research
Phosphorylation of SMAD3 in immune cells predicts survival of patients with early stage non-small cell lung cancer

Authors

  • Sebastian Marwitz Pathology, Research Center Borstel - Leibniz Lung Center, Borstel, GermanyAirway Research Center North (ARCN), German Center for Lung Research (DZL), Großhansdorf, Germany PubMed articlesGoogle scholar articles
  • Carmen Ballesteros-Merino Laboratory of Molecular and Tumor Immunology, Earle A Chiles Research Institute, Portland, Oregon, USA PubMed articlesGoogle scholar articles
  • Shawn M Jensen Laboratory of Molecular and Tumor Immunology, Earle A Chiles Research Institute, Portland, Oregon, USA PubMed articlesGoogle scholar articles
  • Martin Reck Airway Research Center North (ARCN), German Center for Lung Research (DZL), Großhansdorf, GermanyOncology, LungenClinic Grosshansdorf GmbH, Grosshansdorf, Schleswig-Holstein, Germany PubMed articlesGoogle scholar articles
  • Christian Kugler Airway Research Center North (ARCN), German Center for Lung Research (DZL), Großhansdorf, GermanySurgery, LungenClinic Grosshansdorf GmbH, Grosshansdorf, Schleswig-Holstein, Germany PubMed articlesGoogle scholar articles
  • Sven Perner Airway Research Center North (ARCN), German Center for Lung Research (DZL), Großhansdorf, GermanyPathology, University Medical Center Schleswig Holstein, Campus Lübeck, Lübeck, Schleswig-Holstein, Germany PubMed articlesGoogle scholar articles
  • Daniel Drömann Airway Research Center North (ARCN), German Center for Lung Research (DZL), Großhansdorf, GermanyMedical Clinic III Pneumology, University Medical Center Schleswig Holstein, Campus Lübeck, Lübeck, Schleswig-Holstein, Germany PubMed articlesGoogle scholar articles
  • Torsten Goldmann Pathology, Research Center Borstel - Leibniz Lung Center, Borstel, GermanyAirway Research Center North (ARCN), German Center for Lung Research (DZL), Großhansdorf, Germany PubMed articlesGoogle scholar articles
  • Bernard A Fox Laboratory of Molecular and Tumor Immunology, Earle A Chiles Research Institute, Portland, Oregon, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Sebastian Marwitz; smarwitz{at}fz-borstel.de
View Full Text

Citation

Marwitz S, Ballesteros-Merino C, Jensen SM, et al
Phosphorylation of SMAD3 in immune cells predicts survival of patients with early stage non-small cell lung cancer

Publication history

  • Accepted November 30, 2020
  • First published February 15, 2021.
Online issue publication 
February 15, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.